Concentrating capacity of the human reduced folate carrier (hRFC1) in human ZR-75 breast cancer cell lines

Biochemical Pharmacology

Volumn 55, Issue 10, 1998, Pages 1683-1689

  Sharif, Karim A ^a   Moscow, Jeffrey A ^b   Goldman, I David ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Folate; Methotrexate; Reduced folate carrier; Transport

Indexed keywords

CARRIER PROTEIN; METHOTREXATE; METHOTREXATE DERIVATIVE; POLYGLUTAMIC ACID; REDUCED FOLATE CARRIER; UNCLASSIFIED DRUG;

ANION EXCHANGE; ARTICLE; CANCER CELL CULTURE; CELL LEVEL; CELL MEMBRANE TRANSPORT; CONTROLLED STUDY; DRUG BINDING; DRUG TRANSPORT; DRUG UPTAKE; ENZYME ACTIVITY; GENE OVEREXPRESSION; GENETIC TRANSFECTION; GROWTH INHIBITION; HUMAN; HUMAN CELL; INTRACELLULAR TRANSPORT; MEMBRANE CURRENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEADY STATE;

ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; BIOLOGICAL TRANSPORT; BREAST NEOPLASMS; CARRIER PROTEINS; CELL DIVISION; FOLIC ACID; HUMANS; MEMBRANE PROTEINS; MEMBRANE TRANSPORT PROTEINS; METHOTREXATE; MICE; TUMOR CELLS, CULTURED;

EID: 0032525038     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(98)00039-2     Document Type: Article

References (39)

1. Goldman ID, Lichtenstein NS, Oliverio VT. Carrier-mediated transport of the folic acid analogue, methotrexate, in the L1210 leukemia cell. J Biol Chem. 243:1968;5007-5017.
2. Goldman ID, Matherly LH. The cellular pharmacology of methotrexate. Pharmacol Ther. 28:1985;77-102.
3. Sirotnak FM. Correlates of folate analog transport, pharmacokinetics and selective antitumor action. Goldman ID. Membrane Transport of Antineoplastic Agents. 1986;241-281 Pergamon Press, Oxford.
4. Henderson GB. Folate-binding proteins. Annu Rev Nutr. 10:1990;319-335.
5. Dixon KH, Lanpher BC, Chiu J, Kelley K, Cowan KH. A novel cDNA restores reduced folate carrier activity and methotrexate sensitivity to transport deficient cells. J Biol Chem. 269:1994;17-20.
6. Moscow JA, Gong MK, He R, Sgagias MK, Dixon KH, Anzick SL, Meltzer PS, Cowan KH. Isolation of a gene encoding a human reduced folate carrier (RFC1) and analysis of its expression in transport-deficient, methotrexate-resistant human breast cancer cells. Cancer Res. 55:1995;3790-3794.
7. Wong SC, Proefke SA, Bhushan A, Matherly LH. Isolation of human cDNAs that restore methotrexate sensitivity and reduced folate carrier activity in methotrexate transport-defective Chinese hamster ovary cells. J Biol Chem. 270:1995;17468-17475.
8. Williams FMR, Murray RC, Underhill TM, Flintoff WF. Isolation of a hamster cDNA clone coding for a function involved in methotrexate uptake. J Biol Chem. 269:1994;5810-5816.
9. Williams FMR, Flintoff WF. Isolation of a human cDNA that complements a mutant hamster cell defective in methotrexate uptake. J Biol Chem. 270:1995;2987-2992.
10. Prasad PD, Ramamoorthy S, Leibach FH, Ganapathy V. Molecular cloning of the human placental folate transporter. Biochem Biophys Res Commun. 206:1995;681-687.
11. Goldman ID. The characteristics of the membrane transport of amethopterin and the naturally occurring folates. Ann NY Acad Sci. 186:1971;400-422.
12. Yang C-H, Sirotnak FM, Dembo M. Interaction between anions and the reduced folate/methotrexate transport system in L1210 cell plasma membrane vesicles Directional symmetry and anion specificity for differential mobility of loaded and unloaded carrier . J Membr Biol. 79:1984;285-292.
13. Henderson GB, Zevely EM. Structural requirements for anion substrates of the methotrexate transport system of L1210 cells. Arch Biochem Biophys. 221:1983;438-446.
14. Henderson GB, Zevely EM. Anion exchange mechanism for transport of methotrexate in L1210 cells. Biochem Biophys Res Commun. 99:1981;163-169.
15. Henderson GB, Zevely EM. Intracellular phosphate and its possible role as an exchange anion for active transport of methotrexate in L1210 cells. Biochem Biophys Res Commun. 104:1982;474-482.
16. Brigle KE, Westin EH, Houghton MT, Goldman ID. Characterization of two cDNAs encoding folate-binding proteins from L1210 murine leukemia cells. Increased expression associated with a genomic rearrangement. J Biol Chem. 266:1991;17243-17249.
17. Spinella MJ, Brigle KE, Sierra EE, Goldman ID. Distinguishing between folate receptor-α-mediated transport and reduced folate carrier-mediated transport in L1210 leukemia cells. J Biol Chem. 270:1995;7842-7849.
18. Antony AC. The biological chemistry of folate receptors. Blood. 79:1992;2807-2820.
19. Kamen BA, Wang M, Streckfuss AJ, Peryea X, Anderson RGW. Delivery of folates to the cytoplasm of MA104 cells is mediated by a surface membrane receptor that recycles. J Biol Chem. 263:1988;13602-13609.
20. Rothberg KG, Ying Y, Kolhouse JF, Kamen BA, Anderson RGW. The glycophospholipid-linked folate receptor internalizes folate without entering the clathrin-coated pit endocytic pathway. J Cell Biol. 110:1990;637-649.
21. Henderson GB, Strauss BP. Characteristics of a novel transport system for folate compounds in wild-type and methotrexate-resistant L1210 cells. Cancer Res. 50:1990;1709-1714.
22. Sierra EE, Brigle KE, Spinella MJ, Goldman ID. pH dependence of methotrexate transport by the reduced folate carrier and the folate receptor in L1210 leukemia cells. Further evidence for a third route mediated at low pH. Biochem Pharmacol. 53:1997;223-231.
23. Goldman ID. Transport energetics of the folic acid analogue, methotrexate, in L1210 cells Enhanced accumulation by metabolic inhibitors . J Biol Chem. 244:1969;3779-3785.
24. Henderson GB. Separation and inhibitor specificity of a second unidirectional efflux route for methotrexate in L1210 cells. Biochim Biophys Acta. 1110:1992;137-143.
25. Schlemmer SR, Sirotnak FM. Energy-dependent efflux of methotrexate in L1210 leukemia cells. Evidence for the role of an ATPase obtained with inside-out plasma membrane vesicles. J Biol Chem. 267:1992;14746-14752.
26. Zhao R, Seither R, Brigle KE, Sharina IG, Wang PJ, Goldman ID. Impact of overexpression of the reduced folate carrier (RFC1), an anion exchanger, on concentrative transport in murine L1210 leukemia cells. J Biol Chem. 272:1997;21207-21212.
27. Sirotnak FM, Moccio DM, Yang C-H. A novel class of genetic varients of the L1210 cell up-regulated for folate analogue transport inward. J Biol Chem. 259:1984;13139-13144.
28. Jansen G, Westerhof GR, Jarmuszewski MJA, Kathmann I, Rijksen G, Schornagel JH. Methotrexate transport in variant human CCRF-CEM leukemia cells with elevated levels of the reduced folate carrier. Selective effect on carrier-mediated transport of physiological concentrations of reduced folates. J Biol Chem. 265:1990;18272-18277.
29. Matherly LH, Czajkowski CA, Angeles SM. Identification of a highly glycosylated methotrexate membrane carrier in K562 human erythroleukemia cells up-regulated for tetrahydrofolate cofactor and methotrexate transport. Cancer Res. 51:1991;3420-3426.
30. Engel LW, Young NA, Tralka TS, Lippman ME, O'Brien SJ, Joyce MJ. Establishment and characterization of three new continuous cell lines derived from human breast carcinomas. Cancer Res. 38:1978;3352-3364.
31. Cowan KH, Jolivet J. A methotrexate-resistant human breast cancer cell line with multiple defects, including diminished formation of methotrexate polyglutamates. J Biol Chem. 259:1984;10793-10800.
32. Spinella MJ, Brigle KE, Freemantle SJ, Sierra EE, Goldman ID. Comparison of methotrexate polyglutamylation in L1210 leukemia cells when influx is mediated by the reduced folate carrier or the folate receptor. Lack of evidence for influx route-specific effects. Biochem Pharmacol. 52:1996;703-712.
33. Bertino JR, Perkins JP, Johns DG. Purification and properties of dihydrofolate reductase from Ehrlich ascites carcinoma cells. Biochemistry. 4:1965;839-846.
34. Mathews CK, Scrimgeour KG, Huennekens FM. Dihydrofolate reductase. Methods Enzymol. 6:1963;364-368.
35. Skehan P, Storeng R, Scudiero D, Monks A, McMahon J, Vistica D, Warren JT, Bokesch H, Kenney S, Boyd MR. New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst. 82:1990;1107-1112.
36. Brigle KE, Seither RL, Westin EH, Goldman ID. Increased expression and genomic organization of a folate-binding protein homologous to the human placental isoform in L1210 murine leukemia cells with a defective reduced folate carrier. J Biol Chem. 269:1994;4267-4272.
37. Fry DW, Yalowich JC, Goldman ID. Rapid formation of poly-γ-glutamyl derivatives of methotrexate and their association with dihydrofolate reductase as assessed by high pressure liquid chromatography in the Ehrlich ascites tumor cell in vitro. J Biol Chem. 257:1982;1890-1896.
38. Wong SC, McQuade R, Proefke SA, Bhushan A, Matherly LH. Human K562 transfectants expressing high levels of reduced folate carrier but exhibiting low transport activity. Biochem Pharmacol. 53:1997;199-206.
39. Dixon KH, Trepel JB, Eng SC, Cowan KH. Folate transport and the modulation of antifolate sensitivity in a methotrexate-resistant human breast cancer cell line. Cancer Commun. 3:1991;357-365.